Sarilumab Subcutaneous and Tafenoquine (Malaria Prevention)
Determining the interaction of Sarilumab Subcutaneous and Tafenoquine (Malaria Prevention) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: sarilumab
Brand name: Kevzara, Kevzara Pre-filled Pen
Synonyms: Sarilumab
Generic Name: tafenoquine
Brand name: Arakoda, Krintafel
Synonyms: Tafenoquine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Sarilumab Subcutaneous-Tafenoquine (Prevention of Malaria Relapse)
- Sarilumab Subcutaneous-Tafenoquine Succinate (Arakoda)
- Sarilumab Subcutaneous-Tafenoquine Succinate (Krintafel)
- Sarilumab Subcutaneous-Tafinlar
- Sarilumab Subcutaneous-Tafluprost
- Sarilumab Subcutaneous-Tafluprost ophthalmic
- Tafenoquine (Malaria Prevention)-Sarna Hc Topical application
- Tafenoquine (Malaria Prevention)-Sarnol-HC
- Tafenoquine (Malaria Prevention)-Sarnol-HC Maximum Strength
- Tafenoquine (Malaria Prevention)-SAStid
- Tafenoquine (Malaria Prevention)-Sastid Soap Topical
- Tafenoquine (Malaria Prevention)-SAStid Topical